|
My HealtheVet
Anemia, Hemolytic, Acquired Autoimmune
What Is Hemolytic Anemia
The two main types of hemolytic anemia are inherited and Acquired. In inherited hemolytic anemia, the condition is passed from parent to child. In Acquired hemolytic anemia, the person develops the condition from some other cause. Hemolytic anemia can begin rapidly or come on gradually and can range from mild to severe.
Hemolytic Anemia - All Sections (printer-friendly)
In Acquired types of hemolytic anemia, the body produces normal red blood cells, but some disease or other factor destroys the cells prematurely. The destruction of red blood cells can be caused by an immune disorder, infection, reaction to a medicine, or reaction to a transfusion. The early destruction of cells usually occurs in the spleen or the bloodstream. The spleen is an organ in the upper left part of the abdomen that helps remove abnormal blood cells from the bloodstream.
MedlinePlus
Medical Encyclopedia: Idiopathic autoimmune hemolytic anemia
Idiopathic autoimmune hemolytic anemia is an Acquired disease that occurs when antibodies form against a person's own red blood cells. In the idiopathic form of this disease, the cause is unknown.
REACTIVITY OF RED CELL ELUATES AND SERUMS IN PATIENTS WITH ACQUIRED HEMOLYTIC ANEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA
REACTIVITY OF RED CELL ELUATES AND SERUMS IN PATIENTS WITH Acquired HEMOLYTIC ANEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA
Characteristics of autoimmune hemolytic anemia (AIHA) in HIV-infected children.
Characteristics of autoimmune hemolytic anemia (AIHA) in HIV-infected children.
Reticulocytopenic immune hemolytic anemia in an AIDS patient.
Reticulocytopenic immune hemolytic anemia in an AIDS patient.
Idiopathic Acquired Hemolytic Anemia
Idiopathic Acquired Hemolytic Anemia
autoimmune hemolytic anemia
autoimmune hemolytic anemia
Current Trends Risks Associated with Human Parvovirus B19 Infection
Although B19 infection usually produces a mild, self-limited illness, three groups of persons are at risk for serious complications of infection: 1) persons with chronic hemolytic anemias, 2) persons with congenital or Acquired immunodeficiencies, and 3) pregnant women. Since infection in these persons can lead to substantial morbidity and some mortality, consideration should be given to preventing or
Natural History of Sickle Cell Disease and Other Hemolytic Disorders - Full Text View - ClinicalTrials.gov
This protocol will permit the evaluation and treatment of subjects with hereditary and Acquired hemolytic diseases, to facilitate understanding of the pathogenesis and natural history of vaso-occlusive painful crisis and pulmonary complications of sickle cell disease and related cardiopulmonary complications of other hereditary, Acquired and iatrogenic hemolytic disorders. Patients will be evaluated with a medical history and physical examination and routine laboratory studies will be obtained as needed to assess diagnosis, disease activity, and disease complications and to monitor for treatment-related responses and toxicities. Blood can be obtained, with subject's consent, for research studies evaluating gene/ protein expression and to evaluate the role of vasodialators, vasoconstrictors, inflammatory and redox stress mediators in this population. Patients identified with pulmonary hypertension will have the option to undergo invasive hemodynamic evaluation and treatment with FDA approved drugs, according to current standards of medical practice, with signed informed consent for all offered procedures. Patients eligible for other research protocols will be offered an opportunity to participate in theses studies by signed informed consent. Apart from such protocols, any medical care recommended or provided to the patient will be consistent with routine standards of practice and will be provided in consultation with the patient's referring physician. The establishment of this protocol will provide a means to evaluate and treat patients, and to generate hypotheses and protocols based on this clinical experience in sickle cell disease and in other Acquired or inherited hemolytic anemias.
Energy Citations Database (ECD) - - Document #7076019
Anemia is a common phenomenon in women during the reproductive years.^In pregnancy, it is associated with an increased incidence of maternal-fetal morbidity and mortality.^The approach to the investigation of anemic women suspected of having hemolytic anemia of either congenital or Acquired etiology is the subject of this article.^Various conditions in the pregnant women can have hematologic consequences for the newborn infant; these conditions include sensitization to fetal blood cells, infections, drug ingestion and the possession of genes for hereditary hemolytic disorders, which may be transmitted to the fetus.^Because several forms of hemolytic anemias are hereditary or are caused by an altered gene, genetic consultation is important.
FloridaHealthFinder.gov | Health Encyclopedia | Hematology
FloridaHealthFinder.gov | Health Encyclopedia | Hematology
Thrombotic thrombocytopenic purpura - Genetics Home Reference
Thrombotic thrombocytopenic purpura - Genetics Home Reference
Paroxysmal nocturnal hemoglobinuria - Genetics Home Reference
Paroxysmal nocturnal hemoglobinuria - Genetics Home Reference
NIDDK Clearinghouses Reference Collection
NIDDK Clearinghouses Reference Collection
Clinical Study: 04-H-0161, Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Clinical Study: 04-H-0161, Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders
MedlinePlus
Medical Encyclopedia: Immune hemolytic anemia
Immune hemolytic anemia occurs when antibodies form against the body's own red blood cells. The antibodies will destroy the blood cells because these blood cells are recognized as foreign material within the body. The antibodies may be Acquired by blood transfusion, pregnancy (if the baby's blood type is different from the mother's), as a complication of another disease, or from a reaction to medications.
|